Aethlon Medical to merge with North Immunology; ~$180M financing
Aethlon Medical entered a definitive all-stock merger with North Immunology and an oversubscribed private placement of about $180M, expected to fund operations into 2H 2028. Pre-merger Aethlon holders are expected to own about 4.75% of the combined company.
Story updates
10:34:30 AM UTC
SquawkNews
Aethlon Medical Entered Into Merger for All-Stk Transaction With North Immunology, Aethlon Subsidiaries Nighthawk Merger Sub Corp and Nighthawk Second Merger Sub, LLC >AEMD
Aethlon Medical entered a definitive all-stock merger with North Immunology, alongside an oversubscribed approximately $180M private placement expected to fund operations into 2H 2028. 75% of the combined company.